Bailee Malivoire, Ph.D.
SHE/HER
CALIFORNIA PSY34477
MICHIGAN 6301019690
My area of expertise is in helping people overcome anxiety and obsessive-compulsive disorder (OCD) using proven, evidence-based therapies. Research shows that conditions like these are often maintained by specific underlying processes—such as perfectionism, avoidance, over-control, and difficulty tolerating uncertainty. My clinical and research work includes identifying and targeting the patterns that keep anxiety and OCD going, so we can create lasting, meaningful change.
I also offer couples therapy to help partners break out of unhelpful relational patterns that may reinforce anxiety, OCD symptoms, or emotional distress. Drawing from CBT and DBT-based approaches, I work with couples struggling with communication difficulties, emotional reactivity, chronic invalidation, conflict avoidance, and difficulty feeling seen or supported in the relationship. Through this work, partners reduce conflict and emotional reactivity, strengthen emotional safety and connection, and build more effective ways of communicating and responding to one another.
My approach is warm, thoughtful, and collaborative. I tailor treatment to each person’s unique history, identity, and goals—blending compassionate understanding with practical tools to help you get unstuck and move forward in meaningful ways.
I work with adults and specialize in treating:
Excessive worry and difficulties coping with uncertainty
Interpersonal struggles and relationship challenges
Perfectionism and the pressure to meet unrealistically high standards
Physical anxiety and panic attacks
Social anxiety and fear of judgment
Obsessive-Compulsive Disorder (OCD), including intrusive thoughts and compulsive behaviors
Emotional regulation, including difficulty managing strong and overwhelming feelings
Adjusting to major life transitions, such as parenthood, career changes, and other significant shifts
Depression and feelings of persistent sadness
Procrastination and challenges with motivation
TRAINING AND QUALIFICATIONS
I am a licensed psychologist (PSY34477) and Clinical Assistant Professor in the Anxiety and Depression Adult Psychological Treatment (ADAPT) Clinic in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. I earned my Ph.D. in Clinical Psychology from Toronto Metropolitan University. I completed my clinical internship at St. Joseph’s Healthcare Hamilton, followed by postdoctoral training at Stanford University’s School of Medicine, where I specialized in treating mood and anxiety disorders, obsessive-compulsive disorder (OCD), and emotional regulation difficulties. I have authored 20 journal articles focused on the complex factors that contribute to anxiety symptoms and ways to enhance treatment outcomes. My research explores the role that significant others can play in the persistence of anxiety, offering valuable insights into how interpersonal dynamics influence mental health.
TREATMENT OUTCOMES
Data from 14 patients who worked with Dr. Malivoire
Research shows that clinicians who receive regular feedback about how a patient is doing will have better therapy outcomes. The above graph shows treatment outcomes for patients with whom I used the Depression Anxiety and Stress Scale 21 (also called the DASS 21) to track progress. Please note that I only included patients who showed an elevated score at the start of treatment and who completed at least three sessions of therapy.
Depression. The average patient struggling with depression came in with a score of 22 (severe) and ended treatment with a score of 8 (in the normal range). 92% of patients experienced what is considered to be a clinically significant change in symptoms.
Anxiety. The average patient struggling with anxiety came in with a score of 19 (severe) and ended with a score of 8 (in the mild range). 80% of patients experienced what is considered to be a clinically significant change in symptoms.
Stress.The average patient struggling with irritability/stress came in with a score of 24 (moderate) and ended with a score of 13 (in the normal range). 67% of patients experienced what is considered to be a clinically significant change in symptoms.